Although commonly used TRM surface markers such as CD103 and CD69 have been applied in studies of other tumour types, previous research has shown that the expression of TRM‐associated markers varies across tissues and exhibits a degree of tissue specificity. This evidence concerns the gene ITGAE and neoplasm.